Robert K. Bright

2.0k total citations
60 papers, 1.5k citations indexed

About

Robert K. Bright is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Robert K. Bright has authored 60 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 27 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Robert K. Bright's work include Immunotherapy and Immune Responses (26 papers), Virus-based gene therapy research (10 papers) and Polyomavirus and related diseases (8 papers). Robert K. Bright is often cited by papers focused on Immunotherapy and Immune Responses (26 papers), Virus-based gene therapy research (10 papers) and Polyomavirus and related diseases (8 papers). Robert K. Bright collaborates with scholars based in United States, Australia and France. Robert K. Bright's co-authors include Michael H. Shearer, Jennifer A. Byrne, Harvey I. Pass, Ronald C. Kennedy, Gregory P. Kalemkerian, Viji Shridhar, R C Kennedy, Yoh Watanabe, Jennifer D. Lewis and Michele Carbone and has published in prestigious journals such as Nature, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

Robert K. Bright

60 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert K. Bright United States 22 670 497 477 316 202 60 1.5k
Purnima Dubey United States 20 556 0.8× 583 1.2× 487 1.0× 253 0.8× 141 0.7× 45 1.5k
Polly D. Gregor United States 17 1.1k 1.6× 822 1.7× 322 0.7× 310 1.0× 114 0.6× 28 2.0k
Stefanie Mandl United States 14 789 1.2× 234 0.5× 442 0.9× 134 0.4× 323 1.6× 25 1.4k
Ralph F. Hopkins United States 16 570 0.9× 660 1.3× 493 1.0× 235 0.7× 100 0.5× 22 1.8k
Adriaan D. Bins Netherlands 19 444 0.7× 752 1.5× 451 0.9× 161 0.5× 107 0.5× 41 1.5k
Suzana S. Couto United States 24 1.2k 1.8× 451 0.9× 644 1.4× 374 1.2× 221 1.1× 55 2.1k
Valeri H. Terry United States 16 563 0.8× 272 0.5× 299 0.6× 306 1.0× 165 0.8× 24 1.8k
Charles A. Nicolette United States 24 1.3k 1.9× 871 1.8× 579 1.2× 172 0.5× 155 0.8× 51 2.1k
Marco Bestagno Italy 25 800 1.2× 462 0.9× 552 1.2× 101 0.3× 116 0.6× 51 1.9k
Ann Cheung United States 11 716 1.1× 517 1.0× 696 1.5× 80 0.3× 172 0.9× 17 1.5k

Countries citing papers authored by Robert K. Bright

Since Specialization
Citations

This map shows the geographic impact of Robert K. Bright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert K. Bright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert K. Bright more than expected).

Fields of papers citing papers by Robert K. Bright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert K. Bright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert K. Bright. The network helps show where Robert K. Bright may publish in the future.

Co-authorship network of co-authors of Robert K. Bright

This figure shows the co-authorship network connecting the top 25 collaborators of Robert K. Bright. A scholar is included among the top collaborators of Robert K. Bright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert K. Bright. Robert K. Bright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martinez‐Marin, Dalia, Beverly S. Chilton, Robert K. Bright, et al.. (2023). Sertoli Cells Express Accommodation, Survival, and Immunoregulatory Factors When Exposed to Normal Human Serum. Biomedicines. 11(6). 1650–1650. 4 indexed citations
2.
Castro‐Piedras, Isabel, Monica Sharma, Jennifer Brelsfoard, et al.. (2021). Nuclear Dishevelled targets gene regulatory regions and promotes tumor growth. EMBO Reports. 22(6). e50600–e50600. 19 indexed citations
3.
Dong, Ziye, Dan Yu, Qingye Liu, et al.. (2018). Enhanced capture and release of circulating tumor cells using hollow glass microspheres with a nanostructured surface. Nanoscale. 10(35). 16795–16804. 27 indexed citations
4.
Bright, Robert K., et al.. (2014). Overexpressed oncogenic tumor-self antigens. Human Vaccines & Immunotherapeutics. 10(11). 3297–3305. 49 indexed citations
5.
Byrne, Jennifer A., et al.. (2013). Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen. OncoImmunology. 2(7). e25049–e25049. 8 indexed citations
6.
Shearer, Michael H., Cynthia Jumper, Gary L. White, et al.. (2008). Evidence of simian virus 40 exposure in a colony of captive baboons. Virology. 377(1). 54–62. 5 indexed citations
7.
Lewis, Jennifer D., et al.. (2007). Induction of Tumorigenesis and Metastasis by the Murine Orthologue of Tumor Protein D52. Molecular Cancer Research. 5(2). 133–144. 55 indexed citations
8.
Payton, Laura, Jennifer D. Lewis, Jennifer A. Byrne, & Robert K. Bright. (2007). Vaccination with metastasis-related tumor associated antigen TPD52 and CpG/ODN induces protective tumor immunity. Cancer Immunology Immunotherapy. 57(6). 799–811. 18 indexed citations
9.
Lowe, Devin B., Michael H. Shearer, James Tarbox, et al.. (2004). In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization. Virology. 332(1). 28–37. 11 indexed citations
10.
11.
Kawakami, Koji, Syed R. Husain, Robert K. Bright, & Raj K. Puri. (2001). Gene transfer of interleukin 13 receptor α2 chain dramatically enhances the antitumor effect of IL-13 receptor–targeted cytotoxin in human prostate cancer xenografts. Cancer Gene Therapy. 8(11). 861–868. 32 indexed citations
12.
Iordanov, Mihail S., John Wong, Susanna M. Rybak, et al.. (2000). Differential Requirement for the Stress-Activated Protein Kinase/c-Jun NH2-Terminal Kinase in RNA Damage-Induced Apoptosis in Primary and in Immortalized Fibroblasts. PubMed. 4(2). 122–128. 30 indexed citations
13.
Pauley, Robert J., Steven J. Santner, Larry Tait, Robert K. Bright, & Richard J. Santen. (2000). RegulatedCYP19Aromatase Transcription in Breast Stromal Fibroblasts1. The Journal of Clinical Endocrinology & Metabolism. 85(2). 837–846. 26 indexed citations
14.
Virgin, Jeffrey B., Patrick Hurley, Fatimah A. Nahhas, et al.. (1999). Isochromosome 8q formation is associated with 8p loss of heterozygosity in a prostate cancer cell line. The Prostate. 41(1). 49–57. 22 indexed citations
15.
Shearer, Michael H., et al.. (1999). Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis. Cancer Immunology Immunotherapy. 47(6). 343–351. 12 indexed citations
16.
Bright, Robert K., Michael H. Shearer, & Ronald C. Kennedy. (1995). Examination of lymphokines induced in mice following immunization with recombinant simian virus 40 large tumor antigen. Cancer Immunology Immunotherapy. 40(3). 206–211. 6 indexed citations
17.
Bright, Robert K., Michael H. Shearer, & Ronald C. Kennedy. (1995). Nucleic Acid Vaccination against Virally Induced Tumorsa. Annals of the New York Academy of Sciences. 772(1). 241–251. 9 indexed citations
18.
19.
Bright, Robert K., Michael H. Shearer, & Ronald C. Kennedy. (1994). SV40 large tumor antigen associated synthetic peptides define native antigenic determinants and induce protective tumor immunity in mice. Molecular Immunology. 31(14). 1077–1087. 13 indexed citations
20.
Mernaugh, Raymond L., Michael H. Shearer, Robert K. Bright, Robert E. Lanford, & Ronald C. Kennedy. (1992). Idiotype network components are involved in the murine immune response to simian virus 40 large tumor antigen. Cancer Immunology Immunotherapy. 35(2). 113–118. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Purnima Dubey Breakdown of academic impact, for papers by Polly D. Gregor Breakdown of academic impact, for papers by Stefanie Mandl Breakdown of academic impact, for papers by Ralph F. Hopkins Breakdown of academic impact, for papers by Adriaan D. Bins Breakdown of academic impact, for papers by Suzana S. Couto Breakdown of academic impact, for papers by Valeri H. Terry Breakdown of academic impact, for papers by Charles A. Nicolette Breakdown of academic impact, for papers by Marco Bestagno Breakdown of academic impact, for papers by Ann Cheung
Rankless by CCL
2026